257 related articles for article (PubMed ID: 22865551)
1. Pathogenetic and predictive value of biomarkers in patients with ALI and lower severity of illness: results from two clinical trials.
Agrawal A; Zhuo H; Brady S; Levitt J; Steingrub J; Siegel MD; Soto G; Peterson MW; Chesnutt MS; Matthay MA; Liu KD
Am J Physiol Lung Cell Mol Physiol; 2012 Oct; 303(8):L634-9. PubMed ID: 22865551
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers of inflammation, coagulation and fibrinolysis predict mortality in acute lung injury.
McClintock D; Zhuo H; Wickersham N; Matthay MA; Ware LB
Crit Care; 2008; 12(2):R41. PubMed ID: 18358078
[TBL] [Abstract][Full Text] [Related]
3. Elevated PAI-1 is associated with poor clinical outcomes in pediatric patients with acute lung injury.
Sapru A; Curley MA; Brady S; Matthay MA; Flori H
Intensive Care Med; 2010 Jan; 36(1):157-63. PubMed ID: 19855955
[TBL] [Abstract][Full Text] [Related]
4. Clara cell protein (CC16), a marker of lung epithelial injury, is decreased in plasma and pulmonary edema fluid from patients with acute lung injury.
Kropski JA; Fremont RD; Calfee CS; Ware LB
Chest; 2009 Jun; 135(6):1440-1447. PubMed ID: 19188556
[TBL] [Abstract][Full Text] [Related]
5. The inflammation-coagulation axis as an important intermediate pathway in acute lung injury.
Levi M; Schultz M
Crit Care; 2008; 12(2):144. PubMed ID: 18466641
[TBL] [Abstract][Full Text] [Related]
6. Prognostic and pathogenetic value of combining clinical and biochemical indices in patients with acute lung injury.
Ware LB; Koyama T; Billheimer DD; Wu W; Bernard GR; Thompson BT; Brower RG; Standiford TJ; Martin TR; Matthay MA;
Chest; 2010 Feb; 137(2):288-96. PubMed ID: 19858233
[TBL] [Abstract][Full Text] [Related]
7. The association between BMI and plasma cytokine levels in patients with acute lung injury.
Stapleton RD; Dixon AE; Parsons PE; Ware LB; Suratt BT;
Chest; 2010 Sep; 138(3):568-77. PubMed ID: 20435656
[TBL] [Abstract][Full Text] [Related]
8. Acute lung injury in patients with traumatic injuries: utility of a panel of biomarkers for diagnosis and pathogenesis.
Fremont RD; Koyama T; Calfee CS; Wu W; Dossett LA; Bossert FR; Mitchell D; Wickersham N; Bernard GR; Matthay MA; May AK; Ware LB
J Trauma; 2010 May; 68(5):1121-7. PubMed ID: 20038857
[TBL] [Abstract][Full Text] [Related]
9. Comparison of hospital mortality and long-term survival in patients with acute lung injury/ARDS vs cardiogenic pulmonary edema.
Schmickl CN; Biehl M; Wilson GA; Gajic O
Chest; 2015 Mar; 147(3):618-625. PubMed ID: 25474475
[TBL] [Abstract][Full Text] [Related]
10. Plasma CC16 levels are associated with development of ALI/ARDS in patients with ventilator-associated pneumonia: a retrospective observational study.
Determann RM; Millo JL; Waddy S; Lutter R; Garrard CS; Schultz MJ
BMC Pulm Med; 2009 Dec; 9():49. PubMed ID: 19958527
[TBL] [Abstract][Full Text] [Related]
11. Randomized clinical trial of activated protein C for the treatment of acute lung injury.
Liu KD; Levitt J; Zhuo H; Kallet RH; Brady S; Steingrub J; Tidswell M; Siegel MD; Soto G; Peterson MW; Chesnutt MS; Phillips C; Weinacker A; Thompson BT; Eisner MD; Matthay MA
Am J Respir Crit Care Med; 2008 Sep; 178(6):618-23. PubMed ID: 18565951
[TBL] [Abstract][Full Text] [Related]
12. Bronchoalveolar and systemic cytokine profiles in patients with ARDS, severe pneumonia and cardiogenic pulmonary oedema.
Schütte H; Lohmeyer J; Rosseau S; Ziegler S; Siebert C; Kielisch H; Pralle H; Grimminger F; Morr H; Seeger W
Eur Respir J; 1996 Sep; 9(9):1858-67. PubMed ID: 8880103
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic utility of C-reactive protein combined with brain natriuretic peptide in acute pulmonary edema: a cross sectional study.
Komiya K; Ishii H; Teramoto S; Takahashi O; Eshima N; Yamaguchi O; Ebi N; Murakami J; Yamamoto H; Kadota J
Respir Res; 2011 Jun; 12(1):83. PubMed ID: 21696613
[TBL] [Abstract][Full Text] [Related]
14. Extracellular thioredoxin levels are increased in patients with acute lung injury.
Callister ME; Burke-Gaffney A; Quinlan GJ; Nicholson AG; Florio R; Nakamura H; Yodoi J; Evans TW
Thorax; 2006 Jun; 61(6):521-7. PubMed ID: 16601094
[TBL] [Abstract][Full Text] [Related]
15. External validation of a biomarker and clinical prediction model for hospital mortality in acute respiratory distress syndrome.
Zhao Z; Wickersham N; Kangelaris KN; May AK; Bernard GR; Matthay MA; Calfee CS; Koyama T; Ware LB
Intensive Care Med; 2017 Aug; 43(8):1123-1131. PubMed ID: 28593401
[TBL] [Abstract][Full Text] [Related]
16. SuPAR and PAI-1 in critically ill, mechanically ventilated patients.
Jalkanen V; Yang R; Linko R; Huhtala H; Okkonen M; Varpula T; Pettilä V; Tenhunen J;
Intensive Care Med; 2013 Mar; 39(3):489-96. PubMed ID: 23100007
[TBL] [Abstract][Full Text] [Related]
17. Pathogenetic and prognostic significance of altered coagulation and fibrinolysis in acute lung injury/acute respiratory distress syndrome.
Ware LB; Matthay MA; Parsons PE; Thompson BT; Januzzi JL; Eisner MD;
Crit Care Med; 2007 Aug; 35(8):1821-8. PubMed ID: 17667242
[TBL] [Abstract][Full Text] [Related]
18. Keratinocyte growth factor expression is suppressed in early acute lung injury/acute respiratory distress syndrome by smad and c-Abl pathways.
Chandel NS; Budinger GR; Mutlu GM; Varga J; Synenki L; Donnelly HK; Zirk A; Eisenbart J; Jovanovic B; Jain M
Crit Care Med; 2009 May; 37(5):1678-84. PubMed ID: 19325470
[TBL] [Abstract][Full Text] [Related]
19. Elevated levels of plasminogen activator inhibitor-1 in pulmonary edema fluid are associated with mortality in acute lung injury.
Prabhakaran P; Ware LB; White KE; Cross MT; Matthay MA; Olman MA
Am J Physiol Lung Cell Mol Physiol; 2003 Jul; 285(1):L20-8. PubMed ID: 12730079
[TBL] [Abstract][Full Text] [Related]
20. The impact of the PAI-1 4G/5G polymorphism on the outcome of patients with ALI/ARDS.
Tsangaris I; Tsantes A; Bonovas S; Lignos M; Kopterides P; Gialeraki A; Rapti E; Orfanos S; Dimopoulou I; Travlou A; Armaganidis A
Thromb Res; 2009 Apr; 123(6):832-6. PubMed ID: 18804848
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
